Effects of immobilization stress on emotional behaviors in dopamine D3 receptor knockout mice

Behavioural Brain Research

Volumn 243, Issue 1, 2013, Pages 261-266

  Xing, Bo ^a,b   Liu, Peng ^a   Jiang, Wen Hui ^a   Liu, Fei ^a   Zhang, Hui ^b   Cao, Guo Fen ^a   Chen, Teng ^a   Dang, Yong Hui ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b Xi'an Mental Health Center   (China)

Author keywords

Anxiety; D3 Receptor; Depression; Immobilization stress; Knockout

Indexed keywords

DOPAMINE 3 RECEPTOR;

ACUTE STRESS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY DISORDER; ARTICLE; CHRONIC STRESS; CONTROLLED STUDY; DEPRESSION; IMMOBILIZATION STRESS; KNOCKOUT MOUSE; MALE; MAZE TEST; MOUSE; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; WILD TYPE;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; DEPRESSION; DISEASE MODELS, ANIMAL; DOPAMINE AGONISTS; IMMOBILIZATION; MICE; MICE, KNOCKOUT; NEUROPSYCHOLOGICAL TESTS; RECEPTORS, DOPAMINE D3; STRESS, PSYCHOLOGICAL;

EID: 84873734688     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2013.01.019     Document Type: Article

References (43)

1. Kennedy S.H., Lam R.W., Cohen N.L., Ravindran A.V. Clinical guidelines for the treatment of depressive disorders. IV. Medications and other biological treatments. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 2001, 46(Suppl 1):38S-58S.
2. Lydiard R.B., Brawman-Mintzer O. Anxious depression. Journal of Clinical Psychiatry 1998, 59(Suppl 18):10-17.
3. Angst J. Depression and anxiety: implications for nosology, course, and treatment. Journal of Clinical Psychiatry 1997, 58(Suppl 8):3-5.
4. Gelenberg A.J. Psychiatric and somatic markers of anxiety: identification and pharmacologic treatment. Primary Care Companion to the Journal of Clinical Psychiatry 2000, 2:49-54.
5. McEwen B.S., Stellar E. Stress and the individual. Mechanisms leading to disease. Archives of Internal Medicine 1993, 153:2093-2101.
6. Shin L.M., Liberzon I. The neurocircuitry of fear, stress, and anxiety disorders. Neuropsychopharmacology 2010, 35:169-191.
7. Orth U., Robins R.W., Meier L.L. Disentangling the effects of low self-esteem and stressful events on depression: findings from three longitudinal studies. Journal of Personality and Social Psychology 2009, 97:307-321.
8. Kim J.M., Kim S.W., Stewart R., Kang H.J., Shin I.S., Jung S.W., et al. Stressful events, stress perception and treatment outcomes in patients with depressive disorders: the CRESCEND study. Journal of Affective Disorders 2011, 133:528-536.
9. Chrousos G.P. Stress and disorders of the stress system. Nature Reviews Endocrinology 2009, 5:374-381.
10. Ulrich-Lai Y.M., Herman J.P. Neural regulation of endocrine and autonomic stress responses. Nature Reviews Neuroscience 2009, 10:397-409.
11. Herman J.P., Figueiredo H., Mueller N.K., Ulrich-Lai Y., Ostrander M.M., Choi D.C., et al. Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness. Frontiers in Neuroendocrinology 2003, 24:151-180.
12. Lupien S.J., McEwen B.S., Gunnar M.R., Heim C. Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nature Reviews Neuroscience 2009, 10:434-445.
13. Pivonello R., Ferone D., Lombardi G., Colao A., Lamberts S.W., Hofland L.J. Novel insights in dopamine receptor physiology. European Journal of Endocrinology 2007, 156(Suppl 1):S13-S21.
14. Alexander N., Osinsky R., Mueller E., Schmitz A., Guenthert S., Kuepper Y., et al. Genetic variants within the dopaminergic system interact to modulate endocrine stress reactivity and recovery. Behavioural Brain Research 2011, 216:53-58.
15. Finlay J.M., Zigmond M.J. The effects of stress on central dopaminergic neurons: possible clinical implications. Neurochemical Research 1997, 22:1387-1394.
16. Borowsky B., Kuhn C.M. D1 and D2 dopamine receptors stimulate hypothalamo-pituitary-adrenal activity in rats. Neuropharmacology 1992, 31:671-678.
17. Beaulieu J.M., Gainetdinov R.R. The physiology, signaling, and pharmacology of dopamine receptors. Pharmacological Reviews 2011, 63:182-217.
18. Diaz M.R., Chappell A.M., Christian D.T., Anderson N.J., McCool B.A. Dopamine D3-like receptors modulate anxiety-like behavior and regulate GABAergic transmission in the rat lateral/basolateral amygdala. Neuropsychopharmacology 2011, 36:1090-1103.
19. Mah L., Zarate C.A., Nugent A.C., Singh J.B., Manji H.K., Drevets W.C. Neural mechanisms of antidepressant efficacy of the dopamine receptor agonist pramipexole in treatment of bipolar depression. International Journal of Neuropsychopharmacology 2011, 14:545-551.
20. Xu M., Koeltzow T.E., Santiago G.T., Moratalla R., Cooper D.C., Hu X.T., et al. Dopamine D3 receptor mutant mice exhibit increased behavioral sensitivity to concurrent stimulation of D1 and D2 receptors. Neuron 1997, 19:837-848.
21. Maj J., Dziedzicka-Wasylewska M., Rogoz R., Rogoz Z. Effect of antidepressant drugs administered repeatedly on the dopamine D3 receptors in the rat brain. European Journal of Pharmacology 1998, 351:31-37.
22. Lammers C.H., Diaz J., Schwartz J.C., Sokoloff P. Selective increase of dopamine D3 receptor gene expression as a common effect of chronic antidepressant treatments. Molecular Psychiatry 2000, 5:378-388.
23. Chourbaji S., Brandwein C., Vogt M.A., Dormann C., Mueller R., Drescher K.U., et al. Dopamine receptor 3 (D3) knockout mice show regular emotional behaviour. Pharmacological Research 2008, 58:302-307.
24. Xing B., Kong H., Meng X., Wei S.G., Xu M., Li S.B. Dopamine D1 but not D3 receptor is critical for spatial learning and related signaling in the hippocampus. Neuroscience 2010, 169:1511-1519.
25. Xing B., Guo J., Meng X., Wei S.G., Li S.B. The dopamine D1 but not D3 receptor plays a fundamental role in spatial working memory and BDNF expression in prefrontal cortex of mice. Behavioural Brain Research 2012, 235:36-41.
26. Xing B., Meng X., Wei S., Li S. Influence of dopamine D3 receptor knockout on age-related decline of spatial memory. Neuroscience Letters 2010, 481:149-153.
27. Rodgers R.J., Nikulina E.M., Cole J.C., Dopamine D1 D2 receptor ligands modulate the behaviour of mice in the elevated plus-maze. Pharmacology Biochemistry and Behavior 1994, 49:985-995.
28. Steiner H., Fuchs S., Accili D. D3 dopamine receptor-deficient mouse: evidence for reduced anxiety. Physiology & Behavior 1997, 63:137-141.
29. Accili D., Fishburn C.S., Drago J., Steiner H., Lachowicz J.E., Park B.H., et al. A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice. Proceedings of the National Academy of Sciences USA 1996, 93:1945-1949.
30. Leggio G.M., Micale V., Le Foll B., Mazzola C., Nobrega J.N., Drago F. Dopamine D3 receptor knock-out mice exhibit increased behavioral sensitivity to the anxiolytic drug diazepam. European Neuropsychopharmacology 2011, 21:325-332.
31. Rogoz Z., Skuza G., Kllodzinska A. Anxiolytic- and antidepressant-like effects of 7-OH-DPAT, preferential dopamine D3 receptor agonist, in rats. Polish Journal of Pharmacology 2004, 56:519-526.
32. Rektorova I., Rektor I., Bares M., Dostal V., Ehler E., Fanfrdlova Z., et al. Pramipexole and pergolide in the treatment of depression in Parkinson's disease: a national multicentre prospective randomized study. European Journal of Neurology 2003, 10:399-406.
33. Barone P., Scarzella L., Marconi R., Antonini A., Morgante L., Bracco F., et al. Pramipexole versus sertraline in the treatment of depression in Parkinson's disease: a national multicenter parallel-group randomized study. Journal of Neurology 2006, 253:601-607.
34. Breuer M.E., Groenink L., Oosting R.S., Buerger E., Korte M., Ferger B., et al. Antidepressant effects of pramipexole, a dopamine D3/D2 receptor agonist, and 7-OH-DPAT, a dopamine D3 receptor agonist, in olfactory bulbectomized rats. European Journal of Pharmacology 2009, 616:134-140.
35. Siuciak J.A., Fujiwara R.A. The activity of pramipexole in the mouse forced swim test is mediated by D2 rather than D3 receptors. Psychopharmacology (Berlin) 2004, 175:163-169.
36. Leggio G.M., Micale V., Drago F. Increased sensitivity to antidepressants of D3 dopamine receptor-deficient mice in the forced swim test (FST). European Neuropsychopharmacology 2008, 18:271-277.
37. Dal-Zotto S., Marti O., Armario A. Glucocorticoids are involved in the long-term effects of a single immobilization stress on the hypothalamic-pituitary-adrenal axis. Psychoneuroendocrinology. 2003, 28:992-1009.
38. Watanabe H. Activation of dopamine synthesis in mesolimbic dopamine neurons by immobilization stress in the rat. Neuropharmacology 1984, 23:1335-1338.
39. Cabib S., Kempf E., Schleef C., Oliverio A., Puglisi-Allegra S. Effects of immobilization stress on dopamine and its metabolites in different brain areas of the mouse: role of genotype and stress duration. Brain Research 1988, 441:153-160.
40. Imperato A., Angelucci L., Casolini P., Zocchi A., Puglisi-Allegra S. Repeated stressful experiences differently affect limbic dopamine release during and following stress. Brain Research 1992, 577:194-199.
41. Belda X., Armario A., Dopamine D1 D2 dopamine receptors regulate immobilization stress-induced activation of the hypothalamus-pituitary-adrenal axis. Psychopharmacology (Berlin) 2009, 206:355-365.
42. Fuller R.W., Snoddy H.D. Elevation of serum corticosterone concentrations in rats by pergolide and other dopamine agonists. Endocrinology 1981, 109:1026-1032.
43. Cabib S., Puglisi-Allegra S. The mesoaccumbens dopamine in coping with stress. Neuroscience & Biobehavioral Reviews 2012, 36:79-89.